Parenteral methotrexate should be given before biological therapy [8]

Rheumatology

Volumn 42, Issue 8, 2003, Pages 1009-1010

  Bingham, S J ^a,b   Buch, M H ^b   Lindsay, S ^b   Pollard, A ^a   White, J ^a   Emery, P ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; FOLIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; BIOLOGICAL THERAPY; BLOOD ANALYSIS; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; LETTER; MOUTH ULCER; NAUSEA; OROPHARYNX CANCER; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; SYSTEMIC DISEASE; TASTE DISORDER; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INJECTIONS, INTRAVENOUS; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0141727725     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg246     Document Type: Letter

References (5)

1. British Society for Rheumatology. Guidelines for prescribing TNF-α blockers in adults with RA. London: British Society for Rheumatology, 2001.
2. Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of 53 months. Arthritis Rheum 1988;31:577-84.
3. Hamilton RA, Kremer JM. Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. Br J Rheumatol 1997;36:86-90.
4. Osman A, Mulherin D. Is parenteral methotrexate worth trying? Ann Rheum Dis 2001;60:432.
5. Burbage G, Gupta R, Lim K. Intramuscular methotrexate in inflammatory rheumatic disease. Ann Rheum Dis 2001;60:1156.